Variability in diagnostic threshold for comedo necrosis among breast pathologists: implications for patient eligibility for active surveillance trials of ductal carcinoma in situ.

MLA

Harrison, Beth T., et al. “Variability in Diagnostic Threshold for Comedo Necrosis among Breast Pathologists: Implications for Patient Eligibility for Active Surveillance Trials of Ductal Carcinoma in Situ.” Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc, vol. 32, no. 9, Sept. 2019, pp. 1257–62. EBSCOhost, https://doi.org/10.1038/s41379-019-0262-4.

APA

Harrison, B. T., Hwang, E. S., Partridge, A. H., Thompson, A. M., & Schnitt, S. J. (2019). Variability in diagnostic threshold for comedo necrosis among breast pathologists: implications for patient eligibility for active surveillance trials of ductal carcinoma in situ. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc, 32(9), 1257–1262. https://doi.org/10.1038/s41379-019-0262-4

Chicago

Harrison, Beth T, E Shelley Hwang, Ann H Partridge, Alastair M Thompson, and Stuart J Schnitt. 2019. “Variability in Diagnostic Threshold for Comedo Necrosis among Breast Pathologists: Implications for Patient Eligibility for Active Surveillance Trials of Ductal Carcinoma in Situ.” Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc 32 (9): 1257–62. doi:10.1038/s41379-019-0262-4.